|

PD-1/PD-L1 inhibitor Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University1
  • Peking Union Medical College Hospital1

Indications

  • Cancer2
  • Biliary Tract Cancer1
  • Lung Cancer1

Other2 trials

An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.
Phase 2
The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.